Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7709468 Imidazo based heterocycles

Patent 7709468 was granted and assigned to Abbott on May, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 13 Jun, 2024

"update inverses"

Golden AI

edited on 13 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12006319 Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one

Edits on 6 Jun, 2024

"update inverses"

Golden AI

edited on 6 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11999740 Fused pyrazine derivatives as A2A / A2B inhibitors

Edits on 1 Feb, 2024

"update inverses"

Golden AI

edited on 1 Feb, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11884665 Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors

Edits on 19 Jan, 2024

"update inverses"

Golden AI

edited on 19 Jan, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11873304 Fused pyrimidine derivatives as A2A/A2B inhibitors

Edits on 30 Oct, 2023

"Add patent abstract"

Golden AI

edited on 30 Oct, 2023

Edits made to:

Article (+120 characters)

Article

Patent abstract

The present invention is directed to novel imidazopyrazine and imidazopyrimidine compounds of formula (I)

Edits on 18 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 18 Sep, 2023

Edits made to:

Infobox (+7 properties)

Infobox

Patent Inventor Names

David J. Calderwood0

Eric C. Brieinlinger0

Gavin C. Hirst0

Kristine E. Frank0

Michael J. Morytko0

Patrick Betschmann0

Richard W. Dixon0

Edits on 14 Jun, 2023

"update inverses"

Golden AI

edited on 14 Jun, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11673894 Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

Edits on 23 May, 2023

"Remove leading 0 from patent number"

Golden AI

edited on 23 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 07709468 Imidazo based heterocycles US Patent 7709468 Imidazo based heterocycles

Infobox

Patent Number

077094680

Patent Number

77094680

Edits on 20 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 20 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=077094680

Edits on 28 Mar, 2023

"Entity importer update"

Golden AI

edited on 28 Mar, 2023

Infobox

Is a

Patent

Current Assignee

Abbott

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

077094680

Date of Patent

May 4, 2010

Patent Application Number

115146260

Date Filed

September 1, 2006

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=077094680

Patent Primary Examiner

‌

Deepak Rao

Edits on 18 Jun, 2022

"Entity importer update"

Golden AI

edited on 18 Jun, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Website URL

https://pdfpiw.uspto.gov/.piw?Docid=07709468

Edits on 4 Dec, 2021

"Created via: Entity Importer"

Golden AI

created this topic on 4 Dec, 2021

Edits made to:

Infobox (+8 properties)

‌

US Patent 07709468 Imidazo based heterocycles

Infobox

Is a

Patent

Current assignee

Abbott

Patent jurisdiction

United States Patent and Trademark Office

Patent number

07709468

Date of patent

May 4, 2010

Patent application number

11514626

Date Filed

September 1, 2006

Patent primary examiner

‌

Deepak Rao

Find more entities like US Patent 7709468 Imidazo based heterocycles

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API